Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-22-000779

← back to feed
Filed
Feb 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Feb 9, 2022 456.58M sh
Cash And Equivalents Q2 2022 · Dec 31, 2021 $9.92M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $10.19M
Cash And Equivalents Q2 2022 · Dec 31, 2020 $8.19M
Cash And Equivalents Q2 2022 · Jun 30, 2020 $6.02M
Current Liabilities Q2 2022 · Dec 31, 2021 $4.49M
Current Liabilities Q2 2022 · Jun 30, 2021 $6.54M
Total Liabilities Q2 2022 · Dec 31, 2021 $6.12M
Total Liabilities Q2 2022 · Jun 30, 2021 $6.79M
Current Assets Q2 2022 · Dec 31, 2021 $9.96M
Current Assets Q2 2022 · Jun 30, 2021 $10.69M
Total Assets Q2 2022 · Dec 31, 2021 $13.07M
Total Assets Q2 2022 · Jun 30, 2021 $14.3M
Net Income Q2 2022 · Sep 30, 2021 −$2.06M
Net Income Q2 2022 · Dec 31, 2020 −$6.17M
Net Income Q2 2022 · Dec 31, 2020 −$7.35M
Net Income Q2 2022 · Sep 30, 2020 −$1.17M
Operating Cash Flow Q2 2022 · Dec 31, 2020 −$4.71M
Stockholders Equity Q2 2022 · Dec 31, 2020 $3.44M
Stockholders Equity Q2 2022 · Sep 30, 2020 $4.67M
Stockholders Equity Q2 2022 · Jun 30, 2020 $1.46M
Sga Expense Q2 2022 · Dec 31, 2020 $231K
Sga Expense Q2 2022 · Dec 31, 2020 $495K
Rd Expense Q2 2022 · Dec 31, 2020 $2.97M
Rd Expense Q2 2022 · Dec 31, 2020 $3.5M
Operating Income Q2 2022 · Dec 31, 2020 −$3.44M
Operating Income Q2 2022 · Dec 31, 2020 −$4.57M
Revenue Q2 2022 · Dec 31, 2020 $0
Revenue Q2 2022 · Dec 31, 2020 $0
Revenue Q2 2022 · Jul 31, 2019 $400K